Paroxysmal nocturnal hemoglobinuria and complement-mediated erythrocyte damage.
The erythrocytes of paroxysmal nocturnal hemoglobinuria are abnormally sensitive to complement-mediated lysis because they are deficient in membrane proteins that regulate the functional activity of complement. All the deficient proteins in paroxysmal nocturnal hemoglobinuria share the common structural feature of being anchored to the cell surface by a glycosyl phosphatidylinositol moiety. Recent studies showed that the first intermediate in the pathway of the glycosyl phosphatidylinositol anchor synthesis is not formed in paroxysmal nocturnal hemoglobinuria cells. This observation suggests that the molecular basis of paroxysmal nocturnal hemoglobinuria is due to an abnormality involving a gene that encodes a protein essential for the normal biosynthesis of the first intermediate. By using expression cloning, the complementary DNA (called phosphatidylinositol glycan class A [PIG-A]) that corrects the abnormality in glycosyl phosphatidylinositol-anchor synthesis in paroxysmal nocturnal hemoglobinuria cells was identified. Subsequent studies showed that the PIG-A gene is located on the X chromosome. Together, these studies provided a molecular explanation for paroxysmal nocturnal hemoglobinuria.
Parker
C J
CJ
University of Utah School of Medicine, Salt Lake City, USA.
D000818:Animals; D015938:Complement Membrane Attack Complex; D004912:Erythrocytes / Q000473:pathology*; D017261:Glycosylphosphatidylinositols / Q000096:biosynthesis; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006457:Hemoglobinuria, Paroxysmal / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D006801:Humans; D009154:Mutation
D015938:Complement Membrane Attack Complex; D017261:Glycosylphosphatidylinositols